Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v4-FR
Language French French
Date Updated 2024-03-07 2024-02-22
Drug Identification Number 02194201 02194201
Brand name TEVA-NYSTATIN TEVA-NYSTATIN
Common or Proper name TEVA-NYSTATIN 100MU/ML DROPS TEVA-NYSTATIN 100MU/ML DROPS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients NYSTATIN NYSTATIN
Strength(s) 100000UNIT 100000UNIT
Dosage form(s) SUSPENSION SUSPENSION
Route of administration ORAL ORAL ORAL ORAL
Packaging size 1L 1L
ATC code A07AA A07AA
ATC description INTESTINALANTIINFECTIVES INTESTINALANTIINFECTIVES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-02-07 2024-02-07
Estimated end date 2024-08-10 2024-03-20
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments